Skip to main content
Premium Trial:

Request an Annual Quote

Hyseq Adds Four to Management Team

Premium

SUNNYVALE, Calif.--Gene-based therapeutics developer, Hyseq here announced four recent additions to its management team: Robert D'Elia, formerly an operations executive with Turner Construction and Eichleay Architects and Engineers, joined Hyseq as senior director of facilities operations; Stephanie Diaz, formerly of Martek Biosciences, joined as director of finance; Andrew Kumamoto came from the law firm McCutchen, Doyle, Brown and Enersen to be Hyseq's director of intellectual property; and Nandini Tandon joined the company as director of corporate development from Chiron where she was commercial development manager.

Hyseq applies the proprietary DNA array technology of its integrated HyX genomics platform to produce gene-based therapeutic product candidates. The company claims that its proprietary HyGenomics database of partial human gene sequences is the world's largest.

Filed under

The Scan

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.

Team Presents Cattle Genotype-Tissue Expression Atlas

Using RNA sequences representing thousands of cattle samples, researchers looked at relationships between cattle genotype and tissue expression in Nature Genetics.

Researchers Map Recombination in Khoe-San Population

With whole-genome sequences for dozens of individuals from the Nama population, researchers saw in Genome Biology fine-scale recombination patterns that clustered outside of other populations.

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.